Published in J Biol Chem on November 16, 2010
Effect of miR-200b on Diabetic Foot Ulcers (miR-200b) | NCT02581098
Tumour angiogenesis regulation by the miR-200 family. Nat Commun (2013) 1.90
miR-210: the master hypoxamir. Microcirculation (2012) 1.56
Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med (2013) 1.30
microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One (2013) 1.26
The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget (2015) 1.18
Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J Immunol (2014) 1.18
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat Commun (2014) 1.17
Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler Thromb Vasc Biol (2012) 1.17
From microRNAs to targets: pathway discovery in cell fate transitions. Curr Opin Genet Dev (2011) 1.15
Regulation of vascular endothelial growth factor signaling by miR-200b. Mol Cells (2011) 1.15
Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. Reprod Sci (2012) 1.11
miRNA in wound inflammation and angiogenesis. Microcirculation (2012) 1.09
Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J Cereb Blood Flow Metab (2013) 1.08
MicroRNA regulons in tumor microenvironment. Oncogene (2014) 1.08
Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin (2013) 1.04
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov (2016) 1.03
EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.02
Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. Arterioscler Thromb Vasc Biol (2012) 1.02
The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem (2012) 0.97
Regulation of angiogenesis by hypoxia: the role of microRNA. Cell Mol Biol Lett (2012) 0.94
Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis. J Biol Chem (2012) 0.94
MicroRNAs and Endothelial (Dys) Function. J Cell Physiol (2015) 0.93
MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. Invest Ophthalmol Vis Sci (2013) 0.92
MicroRNAs: promising new antiangiogenic targets in cancer. Biomed Res Int (2014) 0.91
Snail promotes the cell-autonomous generation of Flk1(+) endothelial cells through the repression of the microRNA-200 family. Stem Cells Dev (2011) 0.91
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes. Front Mol Neurosci (2011) 0.90
miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer (2012) 0.90
microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis. Adv Exp Med Biol (2015) 0.89
Angiogenesis-regulating microRNAs and Ischemic Stroke. Curr Vasc Pharmacol (2015) 0.89
miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Oncogene (2015) 0.88
The short and long of noncoding sequences in the control of vascular cell phenotypes. Cell Mol Life Sci (2015) 0.88
MicroRNAs in skin and wound healing. Methods Mol Biol (2013) 0.88
miR-200b targets GATA-4 during cell growth and differentiation. RNA Biol (2013) 0.88
The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway. Oncogene (2014) 0.87
miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs. J Biol Chem (2013) 0.87
Regulation of serum response factor by miRNA-200 and miRNA-9 modulates oligodendrocyte progenitor cell differentiation. Glia (2012) 0.87
MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicine. Physiol Genomics (2011) 0.87
HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid Redox Signal (2013) 0.87
MicroRNA Targeting to Modulate Tumor Microenvironment. Front Oncol (2016) 0.86
The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease. Curr Opin Immunol (2014) 0.86
CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells. Oncotarget (2014) 0.86
Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy. EBioMedicine (2016) 0.85
The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1α expression in human endothelial cells through a negative feedback loop. FASEB J (2014) 0.85
How microRNAs facilitate reprogramming to pluripotency. J Cell Sci (2012) 0.85
Metabolic stress in the myocardium: adaptations of gene expression. J Mol Cell Cardiol (2012) 0.84
OxymiRs in cutaneous development, wound repair and regeneration. Semin Cell Dev Biol (2012) 0.83
Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis. Am J Physiol Cell Physiol (2013) 0.80
Specific Roles of MicroRNAs in Their Interactions with Environmental Factors. J Nucleic Acids (2012) 0.80
MiRNA inhibition in tissue engineering and regenerative medicine. Adv Drug Deliv Rev (2014) 0.79
Inhibition of ARNT severely compromises endothelial cell viability and function in response to moderate hypoxia. Angiogenesis (2012) 0.79
microRNA and Wound Healing. Adv Exp Med Biol (2015) 0.79
MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition. Sci Rep (2016) 0.78
microRNA-200b as a Switch for Inducible Adult Angiogenesis. Antioxid Redox Signal (2015) 0.78
An Rb1-dependent amplification loop between Ets1 and Zeb1 is evident in thymocyte differentiation and invasive lung adenocarcinoma. BMC Mol Biol (2015) 0.78
Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy. Genes Chromosomes Cancer (2015) 0.78
miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition. Front Pharmacol (2016) 0.77
Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.77
Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics (2016) 0.76
Correction of MFG-E8 Resolves Inflammation and Promotes Cutaneous Wound Healing in Diabetes. J Immunol (2016) 0.76
The role of miR-320a and IL-1β in human chondrocyte degradation. Bone Joint Res (2017) 0.75
Non-Coding RNAs: New Players in Skin Wound Healing. Adv Wound Care (New Rochelle) (2017) 0.75
miRNA in Macrophage Development and Function. Antioxid Redox Signal (2016) 0.75
Ets-1 as an early response gene against hypoxia-induced apoptosis in pancreatic β-cells. Cell Death Dis (2015) 0.75
Differential expression of microRNAs in retinal vasculopathy caused by selective Müller cell disruption. Sci Rep (2016) 0.75
miRNAs: micro-managers of anticancer combination therapies. Angiogenesis (2017) 0.75
Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med (2017) 0.75
miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells. Eur J Cell Biol (2017) 0.75
Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke. FASEB J (2017) 0.75
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01
microRNA target predictions in animals. Nat Genet (2006) 10.76
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008) 10.71
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol (2009) 8.63
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell (2009) 8.33
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res (2008) 7.45
miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA (2008) 5.48
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res (2007) 5.09
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res (2009) 4.88
Clustering and conservation patterns of human microRNAs. Nucleic Acids Res (2005) 4.79
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res (2007) 4.72
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem (2008) 4.69
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res (2007) 4.65
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res (2009) 3.53
MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol (2009) 3.48
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A (2008) 3.03
Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol (1996) 2.79
miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells (2009) 2.64
Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J (2009) 2.21
Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem (2002) 2.15
Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci U S A (2010) 2.11
Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle (2009) 1.97
Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ Res (2007) 1.79
Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.46
Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. Blood (2000) 1.39
Micromanaging vascular biology: tiny microRNAs play big band. J Vasc Res (2009) 1.31
ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol (1999) 1.28
Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur J Cell Biol (2003) 1.22
Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol (1998) 1.22
MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol (2008) 1.22
ViTa: prediction of host microRNAs targets on viruses. Nucleic Acids Res (2006) 1.21
Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res (2005) 1.16
Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol (1997) 1.15
Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point. Free Radic Biol Med (2006) 1.11
Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol Cell Physiol (2009) 1.10
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res (1997) 1.07
Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene (2006) 1.06
Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx. J Biol Chem (2006) 1.03
Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization. Am J Pathol (2004) 0.99
Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. Am J Physiol Renal Physiol (2008) 0.95
Transcription factor 8 activates R-Ras to regulate angiogenesis. Biochem Biophys Res Commun (2008) 0.95
Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1. Exp Biol Med (Maywood) (2006) 0.92
PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1. Biochem J (2007) 0.89
Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis. Cancer Res (2009) 0.87
Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo: role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway. J Vasc Res (2006) 0.87
Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung. Br J Cancer (2002) 0.87
Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement. DNA Cell Biol (2007) 0.86
Microvascular and macrovascular endothelial cells produce different constrictor substances. J Appl Physiol (1985) (1992) 0.80
Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen (2009) 7.29
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res (2009) 4.88
Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circ Res (2008) 2.24
Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci U S A (2010) 2.11
Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One (2010) 1.95
Dermal wound healing is subject to redox control. Mol Ther (2005) 1.89
Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc Natl Acad Sci U S A (2007) 1.87
Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem (2002) 1.81
Cellular protection with proanthocyanidins derived from grape seeds. Ann N Y Acad Sci (2002) 1.63
Tocotrienols: Vitamin E beyond tocopherols. Life Sci (2006) 1.61
Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem (2003) 1.61
Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics (2008) 1.57
Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke (2005) 1.56
miR-210: the master hypoxamir. Microcirculation (2012) 1.56
Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm. Ann N Y Acad Sci (2002) 1.54
Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res (2003) 1.53
Revisiting the essential role of oxygen in wound healing. Am J Surg (2003) 1.52
The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival. Am J Respir Cell Mol Biol (2006) 1.52
Redox signals in wound healing. Biochim Biophys Acta (2008) 1.49
MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics (2010) 1.48
Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.46
Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid Redox Signal (2007) 1.45
Hyperbaric oxygen therapy ameliorates stress-impaired dermal wound healing. Brain Behav Immun (2005) 1.44
Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med (2007) 1.41
Translational informatics: enabling high-throughput research paradigms. Physiol Genomics (2009) 1.41
Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J Biol Chem (2003) 1.40
Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol (1985) (2004) 1.39
Characterization of a preclinical model of chronic ischemic wound. Physiol Genomics (2009) 1.38
Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ Res (2003) 1.35
Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol (2002) 1.33
Micromanaging vascular biology: tiny microRNAs play big band. J Vasc Res (2009) 1.31
Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol Genomics (2006) 1.31
Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces p21 in peri-infarct myocytes. Am J Physiol Heart Circ Physiol (2006) 1.29
Regulation of c-Src activity in glutamate-induced neurodegeneration. J Biol Chem (2007) 1.27
Wound angiogenesis as a function of tissue oxygen tension: a mathematical model. Proc Natl Acad Sci U S A (2008) 1.27
Characterization of the potent neuroprotective properties of the natural vitamin E alpha-tocotrienol. J Neurochem (2006) 1.26
Microarray analysis of gene expression: considerations in data mining and statistical treatment. Physiol Genomics (2006) 1.26
MiRNA in innate immune responses: novel players in wound inflammation. Physiol Genomics (2010) 1.25
Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2008) 1.25
Harnessing hypoxic adaptation to prevent, treat, and repair stroke. J Mol Med (Berl) (2007) 1.23
MicroRNA in cutaneous wound healing: a new paradigm. DNA Cell Biol (2007) 1.19
Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J Immunol (2014) 1.18
Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system? Biochem Biophys Res Commun (2003) 1.18
Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler Thromb Vasc Biol (2012) 1.17
Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat Res (2005) 1.16
Laser microdissection and pressure-catapulting technique to study gene expression in the reoxygenated myocardium. Am J Physiol Heart Circ Physiol (2006) 1.15
Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev (2008) 1.15
Tocotrienol: the natural vitamin E to defend the nervous system? Ann N Y Acad Sci (2004) 1.15
P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts. Mol Biol Cell (2007) 1.13
Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. J Cell Biochem (2011) 1.12
Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point. Free Radic Biol Med (2006) 1.11
miRNA in wound inflammation and angiogenesis. Microcirculation (2012) 1.09
Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J Cereb Blood Flow Metab (2013) 1.08
Tocotrienols: the emerging face of natural vitamin E. Vitam Horm (2007) 1.08
Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing. Free Radic Biol Med (2007) 1.07